Your search returned 8 results.

Results
	1.	Pharmacoeconomics of dabigatran etexilate for prevention of thromboembolism after joint replacement surgery. [electronic resource] by Wolowacz, Sorrel E Producer: 20110620 In: Expert review of pharmacoeconomics & outcomes research vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review. [electronic resource] by Zimovetz, Evelina A Wolowacz, Sorrel E Classi, Peter M Birt, Julie Producer: 20121002 In: Cost effectiveness and resource allocation : C/E vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Docetaxel in combination with doxorubicin and cyclophosphamide as adjuvant treatment for early node-positive breast cancer: a cost-effectiveness and cost-utility analysis. [electronic resource] by Wolowacz, Sorrel E Cameron, David A Tate, Helen C Bagust, Adrian Producer: 20080228 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK. [electronic resource] by Wolowacz, Sorrel E Roskell, Neil Kelly, Steven Maciver, Fiona M Brand, Chris S Producer: 20071219 In: PharmacoEconomics vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis. [electronic resource] by Wolowacz, Sorrel E Roskell, Neil S Plumb, Jonathan M Caprini, Joseph A Eriksson, Bengt I Producer: 20090227 In: Thrombosis and haemostasis vol. 101 Availability: No items available. Save to lists Add to cart (remove)
	6.	Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report. [electronic resource] by Wolowacz, Sorrel E Briggs, Andrew Belozeroff, Vasily Clarke, Philip Doward, Lynda Goeree, Ron Lloyd, Andrew Norman, Richard Producer: 20170512 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States. [electronic resource] by Zuluaga-Sanchez, Santiago Hess, Lisa M Wolowacz, Sorrel E D'yachkova, Yulia Hawe, Emma Vickers, Adrian D Kaye, James A Bertwistle, David Publication details: Sarcoma 2018 In: Sarcoma vol. 2018 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery. [electronic resource] by Wolowacz, Sorrel E Roskell, Neil S Maciver, Fiona Beard, Stephen M Robinson, Paul A Plumb, Jonathan M Dolan, Gerry Brenkel, Ivan J Producer: 20090407 In: Clinical therapeutics vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)